Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New agents for CNS disorders claimed by HHS

Dec. 30, 1996

Beiersdorf-Lilly claims angiotensin II blockers

Dec. 30, 1996

Otsuka describes new analgesics

Dec. 24, 1996

Natural antineoplastic agents described by Fujisawa

Dec. 24, 1996

Bin1 described by Wistar Institute for cancer Rx and Dx

Dec. 24, 1996

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Neuroprotective polypeptide reported by Amgen

Dec. 24, 1996

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

LHRH antagonists under study at Takeda

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...